Allitia DiBernardo

Janssen (United States) — United States

Medicine · Health Sciences

24h-index1.8kcitations64works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Treatment of Major Depression(25), Dementia and Cognitive Impairment Research(10), Alzheimer's disease research and treatments(10), Tryptophan and brain disorders(8), Mental Health Treatment and Access(6)

Publications64 total

Psychiatric outcomes and long-term school and work-related disability in offspring of parents with depression and treatment-resistant depression
Social Psychiatry and Psychiatric Epidemiology·2025Open Access
Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study
Journal of Women s Health·2024· 1 cited
Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine
International Journal of Methods in Psychiatric Research·2022· 25 citedOpen Access
Analysis and Evaluation of Ponesimod Hepatic Safety Data (P1-1.Virtual)
Neurology·2022
Ponesimod Shows Improved Effect on Brain Volume Compared with Other DMTs, A Model Based Meta-Analysis (P1-1.Virtual)
Neurology·2022
Accurate prediction of clinical stroke scales and improved biomarkers of motor impairment from robotic measurements
PLoS ONE·2021· 22 citedOpen Access
A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
PLoS ONE·2020· 24 citedOpen Access
A register-based approach to identifying treatment-resistant depression—Comparison with clinical definitions
PLoS ONE·2020· 26 citedOpen Access
Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform
BMC Psychiatry·2020· 35 citedOpen Access
Patient preferences for ketamine-based antidepressant treatments in treatment-resistant depression: Results from a clinical trial and panel
Neurology Psychiatry and Brain Research·2020· 13 cited
Risk and risk factors for disability pension among patients with treatment resistant depression– a matched cohort study
BMC Psychiatry·2020· 20 citedOpen Access
Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data
The International Journal of Neuropsychopharmacology·2020· 17 citedOpen Access
Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed
Journal of Affective Disorders·2020· 24 cited
142 Withdrawal Symptom Assessment in an Esketamine Safety Study in Patients with Treatment-resistant Depression
CNS Spectrums·2020· 3 citedOpen Access
144 Esketamine Nasal Spray for Management of Treatment-Resistant Depression: Number Needed to Treat, Number Needed to Harm, Likelihood to be Helped/Harmed
CNS Spectrums·2020Open Access
Additional file 2 of Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform
Figshare·2020Open Access
Additional file 3 of Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform
Figshare·2020Open Access
Additional file 1 of Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform
Figshare·2020Open Access
P.039 Risk for disability pension among antidepressant treated patients with and without treatment resistant depression: matched cohort study in Swedish registers
European Neuropsychopharmacology·2019
P.034 Factor analysis of the MADRS over the course of treatment in patients with treatment-resistant depression
European Neuropsychopharmacology·2019
page 1 of 4Next →

Frequent Co-authors

Johan Reutfors(12), Eric Yang(10), Nandini Raghavan(9), Vaibhav A. Narayan(9), Philip Brenner(9), Lena Brandt(9), Michael Farnum(8), Victor S. Lobanov(7), Mahesh N. Samtani(7), Robert Bodén(7), Gerald Novak(6), Stephane Borentain(6), Jaskaran Singh(5), Tim Schultz(4), Merit Cudkowicz(4), Ewa Wajs(4), Ella Daly(4), Leah Aluisio(4), Michael Krams(3), Rudi Verbeeck(3)